Archer-Daniels-Midland Reports Significant Earnings Decline for 2025, Remediates Material Weakness in Internal Controls

summarizeSummary

Archer-Daniels-Midland reported a significant 40% drop in 2025 net earnings and disclosed substantial impairment charges, alongside the positive news of fully remediating a material weakness in internal controls.

check_boxKey Events

• Net Earnings Decline Significantly

  Net earnings attributable to controlling interests decreased by 40% to $1.078 billion ($2.23 diluted EPS) in 2025, down from $1.800 billion ($3.65 diluted EPS) in 2024. Earnings before income taxes also fell by 44% to $1.255 billion.

• Material Weakness in Internal Controls Remediated

  The company announced the full remediation of a previously disclosed material weakness in internal control over financial reporting related to intersegment sales, effective June 30, 2025. This follows the SEC investigation settlement disclosed on January 28, 2026.

• Substantial Impairment and Revaluation Charges

  Total asset impairment, exit, and restructuring costs were $473 million in 2025, including a $179 million impairment for capitalized software and $372 million in revaluation losses on alternative protein investments. A $163 million penalty charge related to the Wilmar equity investment was also recorded.

• Cessation of Share Repurchases

  The company did not repurchase any shares in 2025, a notable change from $2.3 billion in share repurchases during 2024, despite extending its repurchase program through 2029.

auto_awesomeAnalysis

Archer-Daniels-Midland's 2025 annual report reveals a substantial decline in financial performance, with net earnings attributable to controlling interests falling by 40% and earnings before income taxes decreasing by 44% compared to 2024. This downturn was primarily driven by lower pricing, compressed margins in Ag Services and Oilseeds, and significant impairment charges totaling $473 million, including $179 million for capitalized software and $372 million in revaluation losses on alternative protein investments. Additionally, the company recorded a $163 million penalty charge related to its Wilmar equity investment. While the financial results are a clear negative, a critical positive development is the full remediation of the previously disclosed material weakness in internal control over financial reporting as of June 30, 2025, addressing a key concern that led to a recent SEC settlement. The company also reported strong operating cash flow, but notably ceased share repurchases in 2025 after a $2.3 billion program in 2024, and maintains an investment-grade credit rating with a negative outlook. Investors should monitor the impact of ongoing legal proceedings and the effectiveness of strategic initiatives to restore profitability.